Denali Therapeutics Inc. (DNLI) Dropped -8.73% or -1.85 To Price $19.35 On Thursday


Denali Therapeutics Inc. (DNLI) dropped -8.73% or -1.85 to $19.35. It is nearly 643782 shares traded, which is 88.39% compare to the average total volume 728308. The market cap of DNLI is $1.83 billion. The year to date change is 22.71%. The 52 week price range is from $12.32 to $25.79. Price of DNLI have changed -0.14% during last week. It have changed 9.28% over last month, 36.42% over last 3 months, 13.07% over last 6 months and -1.17% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DNLI is 17.45. It is -9.82% below current price. The 200-day Moving Averages for DNLI is 18.60. It is -3.88% below current price. The 52-week High is 25.79. It is 33.28% from the current price. The 52-week Low is 12.32. It is -36.33% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of DNLI is 14.81 on 2018-09-14. Short % to float is 7.08%. There are some statistics of DNLI. It is has market cap $1.83 billion. The share outstanding is 94.81 million. The average volume is 728308. The percent of top 15 Institution holding is 89.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DNLI is -25.12%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DNLI is -21.52%.


Tags:

Share this post